- Home
- SST vs VRCA Comparison
SST vs VRCA Comparison
Compare SST & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | VRCA |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | 300 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 87.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SST | VRCA |
|---|---|---|
| Price | $2.01 | $6.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.00 | ★ $17.00 |
| AVG Volume (30 Days) | 12.9K | ★ 125.6K |
| Earning Date | 01-01-0001 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | $372.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $0.29 | $0.39 |
| 52 Week High | $11.30 | $9.82 |
Technical Indicators
Market Signals| Indicator | SST | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 19.29 | 51.31 |
| Support Level | $0.34 | $5.22 |
| Resistance Level | $4.61 | $6.44 |
| Average True Range (ATR) | 0.31 | 0.46 |
| MACD | -0.10 | 0.16 |
| Stochastic Oscillator | 10.40 | 70.51 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.